Skip to main content
. 2015 Nov 23;14:77–87. doi: 10.1007/s40258-015-0204-3

Fig. 1.

Fig. 1

Varenicline versus market mix for the first quit attempt: net monetary benefit (discounted) by age category. Net monetary benefit = (net QALYs) × ¥5,000,000 − (net direct cost). ¥ Japanese yen, QALYs quality-adjusted life-years